viktchi_chemistry_molecule_light_grey_and_green_white_backgroun_206fd41b-ecf1-4b12-be86-d4

About Us

Algentech is a green biotech company

Specialized in synthetic biology, using its proprietary plant bioproduction platform for the valorization of bio-based components for industry.

Algentech is positioned as a partner, supplier of value-added biobased ingredients for multisectorial applications, harnessing the natural power of plants to sustainably produce biobased products for pharmaceutical, cosmetic and food industries.

The company is a member of the Genopole BioCluster and performs its R&D activities at the University of Paris Saclay.

Our mission is to produce best in class bioproducts combining production efficiency with a positive environmental impact

The Founders

Management team PhD, President and CEO

Alexander Sorokin

Dr Sorokin has a PhD in plant genetics obtained from the Institute of Genetics and Cytology, Minsk. Extensive experience in plant biotechnology and business development. Held several positions as a group leader at the Sainsbury's laboratory in Norwich (UK) and as Head of Innovation at Plant Bioscience Ltd in Norwich (UK). Co-inventor of 7 patents in synthetic biology. Finalist of the 2021 EurekAwards, a competition to discover and support ambitious synthetic biology projects across Europe. Nationality: British.

Management team PhD, Executive Director

Isabelle Malcuit

Dr Malcuit holds a PhD in plant virology received in 1998 from the department of genetics, Trinity College (Dublin, Ireland). Dr Malcuit has extensive experience in genetics and plant biotechnology. Prior to founding Algentech, she held the position of senior research associate at the Sainsbury Laboratory (Norwich, UK), in charge of the programme for functional genomics using VIGS (Virus-Induced Gene Silencing). She is co-inventor on 7 patent families owned by Algentech.

Scientific Board

PhD

Prof. Aidan Coffey

Microbiology, microbiome, biocontrol of pathogenic bacteria, endolysin

Professor at Munster Technological University and Principal Investigator at the Centre for Research in Advanced Therapeutic Engineering (CREATE).

PhD

Prof. Henrik Toft Simonsen

Plant biochemistry, metabolic engineering and biotechnology

Professor at Jean Monnet University, St. Étienne, France & Founder, director of the plant biotechnology laboratory, CEO at Mosspiration Biotech.

PhD

Dr Karl-Michael Schmidt

Lemna production, indoor cultivation of Lemnaceae.

University of Bonn, Institute of Crop Science and Resource Conservation (INRES).

Strategic Board

Laurent Bracco

Ph.D in Molecular Biology: conducted research programs in Oncology within Sanofi before co-founding ExonHit Therapeutics, a gene profiling biotech.

Jacques Tamisier

Polytechnique graduate, Scientific Attaché of US French Embassy in Washington DC; member of Oncodiag strategic board; vice-president of France Angels; former executive director of Orange.

Frédéric Zampatti

Graduated from Toulouse Business School & Master in finance from Nice University; Director of Investment at Scientipole Capital, formerly Deputy CEO of Nutrivercell. Project manager at Genopole. Site manager in agribusiness.

Michel Martin

IT specialist, graduated from ENSEM (Ecole Nationale Supérieure d’Electricité et de Mécanique) and IAE Paris business school; Secretary General at IEAM Paris.

Henri Jannet

Polytechnique graduate, Chairman and CEO of Business Angels des Grandes Ecoles (Badge), one of the most important French networks of Business Angels. Former CEO of Sanef Group.

Jean-Thierry Augustin

Former CEO of Eurosport. Now consultant in major sports related transactions. Investor in various ventures, predominantly e-sports, gaming related and life science.

Alain Verlière

30 years in pharmaceutical industry (Roussel, HMR, Aventis, Sanofi) in France as well as foreign countries as CFO, Country head, VP Latin America Zone and Business Development positions.

Nathalie Ricoeur Nicolai

PhD in economy; founder of Scientipole capital, former project manager at Scientipôle Initiative. Former Deputy Director of economic and financial research at CDC IXIS. AMF Certification.

R&D team

Alena Sarokina

Msc in Biochemistry from Minsk University. Alena joined Algentech in 2011, in charge of the plant transformation platform.

Jana Maslovaric